# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5122827 | B | Inhibition of recombinant human AKR1C3 transfected in Escherichia coli BL21 (DE) assessed as reduction in NADPH production using S-tetralol as substrate by fluorescence based analysis | Homo sapiens | 12 | ALA5120830 | assay format | Scientific Literature | |
2. | ALA5122828 | B | Inhibition of recombinant human AKR1C2 transfected in Escherichia coli BL21 (DE) assessed as reduction in NADPH production at 100 uM using S-tetralol as substrate by fluorescence based analysis relative to control | Homo sapiens | 9 | ALA5120830 | assay format | Scientific Literature | |
3. | ALA5122831 | B | Selectivity index, ratio of inhibition of recombinant human AKR1C2 transfected in Escherichia coli BL21 (DE) to IC50 for inhibition of recombinant human AKR1C3 transfected in Escherichia coli BL21 (DE) | Homo sapiens | 3 | ALA5120830 | assay format | Scientific Literature | |
4. | ALA5122832 | P | Solubility of the compound in PBS at pH 7.4 incubated for 24 hrs by UHPLC analysis | 12 | ALA5120830 | small-molecule physicochemical format | Scientific Literature | ||
5. | ALA5122833 | F | Antiproliferative activity against human 22Rv1 cells expressing AKR1C3 assessed as inhibition of cell growth incubated for 72 hrs by SRB assay | Homo sapiens | 12 | ALA5120830 | cell-based format | Scientific Literature | |
6. | ALA5122836 | P | Lipophilicity, logD of the compound in n-octanol and phosphate buffer at pH 7.4 incubated for 4 hrs by UV-Vis spectrophotometer based shake flask method | 12 | ALA5120830 | small-molecule physicochemical format | Scientific Literature | ||
7. | ALA5122838 | F | Inhibition of prostate specific antigen expression in human 22Rv1 cells expressing AKR1C3 at 5 to 50 uM incubated for 72 hrs by Western blot analysis | Homo sapiens | 2 | ALA5120830 | cell-based format | Scientific Literature | |
8. | ALA5122839 | F | Antiproliferative activity against human 22Rv1 cells expressing AKR1C3 assessed as reduction in cell viability at 40 to 60 uM incubated for 72 hrs in presence of abiraterone by SRB assay relative to either drug alone | Homo sapiens | 2 | ALA5120830 | cell-based format | Scientific Literature | |
9. | ALA5122840 | F | Antiproliferative activity against human 22Rv1 cells expressing AKR1C3 assessed as reduction in cell viability at 40 to 60 uM incubated for 72 hrs in presence of , enzalutamide by SRB assay relative to either drug alone | Homo sapiens | 2 | ALA5120830 | cell-based format | Scientific Literature |